Evidence map›Paper›PMID 33298059›Full record

ArticleHealth and quality of life outcomes2020

Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis.

Zeng Jie Ye, Zhang Zhang, Ying Tang, Jian Liang, Xiao Ying Zhang, Guang Yun Hu, Zhe Sun, Mu Zi Liang, Yuan Liang Yu

Open access · goldAbstract read
In one paragraph

Article in Health and quality of life outcomes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Resilience index improves prediction of 1-year decreased quality of life in breast cancer.Journal of cancer survivorship : research and practice · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Zeng Jie YeGuangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong Province, China. zengjieye@qq.com.ORCID http://orcid.org/0000-0002-4437-3947
Zhang ZhangSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong Province, China.
Ying TangInstitute of Tumor, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong Province, China.
Jian LiangGuangdong Provincial Key Laboratory of New Drug Development and Research of Chinese Medicine, Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong Province, China.
Xiao Ying ZhangThe Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 510275, Guangdong Province, China.
Guang Yun HuArmy Medical University, Chongqing Municipality, 400038, China.
Zhe SunThe First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong Province, China.
Mu Zi LiangGuangdong Academy of Population Development, Guangzhou, 510600, Guangdong Province, China.
Yuan Liang YuSouth China University of Technology, Guangzhou, 510641, Guangdong Province, China.
Guangzhou University of Chinese Medicine · CNSun Yat-sen University · CNArmy Medical University · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNSouth China University of Technology · CN

Funding

Humanity and Social Science Foundation of Department of Education of Guangdong Province 2020WTSCX009Humanity and Social Science Foundation of Guangzhou University of Chinese Medicine 2020SKXK01Humanity and Social Science Youth Foundation of Ministry of Education of China 19YJCZH227Innovative Project of Guangzhou University of Chinese Medicine 2016KYTD08Medical Scientific Research Foundation of Guangdong Province A2019484National Natural Science Foundation of China 71904033Research Fund for Talented Scholars of Guangzhou University of Chinese Medicine A1-AFD018
6 · The paper itself

Abstract

backgroundThe minimum clinical important differences (MCIDs) of resilience instruments in patients with cancer have not been comprehensively described. This study was designed to evaluate MCIDs of 10-item and 25-item resilience scales specific to cancer (RS-SC-10 and RS-SC-25).

methodsFrom June 2015 to December 2018, RS-SCs were longitudinally measured in 765 patients with different cancer diagnoses at baseline (T0) and 3 months later (T1). The EORTC QLQ-C30, Connor-Davidson Resilience Scale, Hospital Anxiety and Depression Scale, and Allostatic Load Index were measured concurrently as anchors. Anchor-based methods (linear regression, within-group), distribution-based methods(within-group), and receiver operating characteristic curves (ROCs, within-subject) were performed to evaluate the MCIDs.

results623 of 765 (84.1%) patients had paired RS-SCs scores. Moderate correlations were identified between the change in RS-SCs and change in anchors (r = 0.38-0.44, all p < 0.001). Linear regression estimated + 8.9 and - 6.7 as the MCIDs of RS-SC-25, and + 3.4 and - 2.5 for RS-SC-10. Distribution-based methods estimated + 9.9 and - 9.9 as the MCIDs of RS-SC-25, and + 4.0 and - 4.0 for RS-SC-10. ROC estimated + 5.5 and - 4.5 as the MCIDs of RS-SC-25, and + 2.0 and - 1.5 for RS-SC-10.

conclusionsThe most reliable MCID is around 5 points for RS-SC-25 and 2 points for RS-SC-10. RS-SCs are more responsive to the worsening status of resilience in patients with cancer and these estimates could be useful in future resilience-based intervention trials.

Indexed as

Minimal Clinically Important DifferenceQuality of LifeResilience, PsychologicalAdultFemaleHumansLongitudinal StudiesMaleMiddle AgedNeoplasmsProspective StudiesROC CurveSurveys and QuestionnairesAnchor-basedCancerDistribution-basedMinimum clinical important differenceNursingResilienceROCRS-SC-10RS-SC-25

Identifiers

PMID33298059
PMCPMC7724855
OpenAlexW3098052083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.